| First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu-and 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary … K Herrmann, M Schottelius, C Lapa, T Osl, A Poschenrieder, H Hänscheid, ... Journal of nuclear medicine 57 (2), 248-251, 2016 | 176 | 2016 |
| In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma K Philipp‐Abbrederis, K Herrmann, S Knop, M Schottelius, M Eiber, ... EMBO molecular medicine 7 (4), 477-487, 2015 | 171 | 2015 |
| Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells S Sbiera, E Leich, G Liebisch, I Sbiera, A Schirbel, L Wiemer, S Matysik, ... Endocrinology 156 (11), 3895-3908, 2015 | 169 | 2015 |
| [68Ga] Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma-Comparison to [18F] FDG and laboratory values C Lapa, M Schreder, A Schirbel, S Samnick, KM Kortüm, K Herrmann, ... Theranostics 7 (1), 205, 2017 | 151 | 2017 |
| Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy K Herrmann, C Bluemel, M Weineisen, M Schottelius, HJ Wester, ... Journal of Nuclear Medicine 56 (6), 855-861, 2015 | 149 | 2015 |
| Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor K Herrmann, C Lapa, HJ Wester, M Schottelius, C Schiepers, U Eberlein, ... Journal of nuclear medicine 56 (3), 410-416, 2015 | 106 | 2015 |
| [123I]Iodometomidate for Molecular Imaging of Adrenocortical Cytochrome P450 Family 11B Enzymes S Hahner, A Stuermer, M Kreissl, C Reiners, M Fassnacht, H Haenscheid, ... The Journal of Clinical Endocrinology & Metabolism 93 (6), 2358-2365, 2008 | 106 | 2008 |
| Impact of 68 Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy C Bluemel, F Linke, K Herrmann, I Simunovic, M Eiber, C Kestler, AK Buck, ... EJNMMI research 6 (1), 1-8, 2016 | 89 | 2016 |
| CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma C Lapa, K Herrmann, A Schirbel, H Hänscheid, K Lückerath, ... Theranostics 7 (6), 1589, 2017 | 85 | 2017 |
| [68Ga] Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer-initial experience C Lapa, K Lückerath, M Rudelius, JS Schmid, A Schoene, A Schirbel, ... Oncotarget 7 (8), 9288, 2016 | 75 | 2016 |
| Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease D Weise, R Lorenz, M Schliesser, A Schirbel, K Reiners, J Classen Movement disorders: official journal of the Movement Disorder Society 24 (11 …, 2009 | 71 | 2009 |
| Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial B Karges, R Muche, I Knerr, W Ertelt, T Wiesel, R Hub, A Neu, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1647-1652, 2007 | 63 | 2007 |
| Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI C Lapa, T Reiter, M Kircher, A Schirbel, RA Werner, T Pelzer, C Pizarro, ... Oncotarget 7 (47), 77807, 2016 | 61 | 2016 |
| Imaging of chemokine receptor 4 expression in neuroendocrine tumors-a triple tracer comparative approach RA Werner, A Weich, T Higuchi, JS Schmid, A Schirbel, M Lassmann, ... Theranostics 7 (6), 1489, 2017 | 60 | 2017 |
| Functional Characterization of Adrenal Lesions Using [123I]IMTO-SPECT/CT S Hahner, MC Kreissl, M Fassnacht, H Haenscheid, S Bock, FA Verburg, ... The Journal of Clinical Endocrinology & Metabolism 98 (4), 1508-1518, 2013 | 58 | 2013 |
| [131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma S Hahner, MC Kreissl, M Fassnacht, H Haenscheid, P Knoedler, K Lang, ... The Journal of Clinical Endocrinology & Metabolism 97 (3), 914-922, 2012 | 58 | 2012 |
| Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma B Heinze, CT Fuss, P Mulatero, F Beuschlein, M Reincke, M Mustafa, ... Hypertension 71 (2), 317-325, 2018 | 54 | 2018 |
| A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging N Chen, Q Zhang, YA Yu, J Stritzker, P Brader, A Schirbel, S Samnick, ... Molecular medicine 15 (5), 144-151, 2009 | 53 | 2009 |
| [177Lu] pentixather: comprehensive preclinical characterization of a first CXCR4-directed endoradiotherapeutic agent M Schottelius, T Osl, A Poschenrieder, F Hoffmann, S Beykan, ... Theranostics 7 (9), 2350, 2017 | 52 | 2017 |
| Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging K Buder, C Lapa, MC Kreissl, A Schirbel, K Herrmann, A Schnack, ... BMC cancer 14 (1), 1-8, 2014 | 52 | 2014 |
